Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Content of autoantibodies to bradykinin and beta-amyloid(1-42) as a criterion for biochemical differences between Alzheimer's dementias.

Myagkova MA, Gavrilova SI, Lermontova NN, Kalyn YB, Selezneva ND, Zharikov GA, Kolykhalov IV, Abramenko TV, Serkova TP, Bachurin SO.

Bull Exp Biol Med. 2003 Jul;136(1):49-52.

PMID:
14534609
2.

Autoantibodies to beta-amyloid and neurotransmitters in patients with Alzheimer's disease and senile dementia of the Alzheimer type.

Myagkova MA, Gavrilova SI, Lermontova NN, Kalyn YB, Selezneva ND, Zharikov GA, Kolykhalov IV, Abramenko TV, Serkova TP, Bachurin SO.

Bull Exp Biol Med. 2001 Feb;131(2):127-9.

PMID:
11391392
3.

Alzheimer's amyloid beta-peptide (1-42) induces cell death in human neuroblastoma via bax/bcl-2 ratio increase: an intriguing role for methionine 35.

Clementi ME, Pezzotti M, Orsini F, Sampaolese B, Mezzogori D, Grassi C, Giardina B, Misiti F.

Biochem Biophys Res Commun. 2006 Mar 31;342(1):206-13. Epub 2006 Feb 3.

PMID:
16472763
4.

Reduced serum level of antibodies against amyloid beta peptide is associated with aging in Tg2576 mice.

Sohn JH, So JO, Kim H, Nam EJ, Ha HJ, Kim YH, Mook-Jung I.

Biochem Biophys Res Commun. 2007 Sep 28;361(3):800-4. Epub 2007 Jul 27.

PMID:
17678618
5.

Autoantibodies to redox-modified oligomeric Abeta are attenuated in the plasma of Alzheimer's disease patients.

Moir RD, Tseitlin KA, Soscia S, Hyman BT, Irizarry MC, Tanzi RE.

J Biol Chem. 2005 Apr 29;280(17):17458-63. Epub 2005 Feb 21.

6.

An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid.

Portelius E, Zetterberg H, Andreasson U, Brinkmalm G, Andreasen N, Wallin A, Westman-Brinkmalm A, Blennow K.

Neurosci Lett. 2006 Dec 6;409(3):215-9. Epub 2006 Oct 17.

PMID:
17049739
7.
8.

Quaternary structure of a mature amyloid fibril from Alzheimer's Abeta(1-40) peptide.

Sachse C, Xu C, Wieligmann K, Diekmann S, Grigorieff N, Fändrich M.

J Mol Biol. 2006 Sep 15;362(2):347-54.

PMID:
16920151
9.
10.

Stabilization of a beta-hairpin in monomeric Alzheimer's amyloid-beta peptide inhibits amyloid formation.

Hoyer W, Grönwall C, Jonsson A, Ståhl S, Härd T.

Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5099-104. doi: 10.1073/pnas.0711731105. Epub 2008 Mar 28.

11.

The toxic conformation of the 42-residue amyloid beta peptide and its relevance to oxidative stress in Alzheimer's disease.

Irie K, Murakami K, Masuda Y, Morimoto A, Ohigashi H, Hara H, Ohashi R, Takegoshi K, Fukuda H, Nagao M, Shimizu T, Shirasawa T.

Mini Rev Med Chem. 2007 Oct;7(10):1001-8. Review.

PMID:
17979802
12.
13.

Small heat shock protein HspB8: its distribution in Alzheimer's disease brains and its inhibition of amyloid-beta protein aggregation and cerebrovascular amyloid-beta toxicity.

Wilhelmus MM, Boelens WC, Otte-Höller I, Kamps B, Kusters B, Maat-Schieman ML, de Waal RM, Verbeek MM.

Acta Neuropathol. 2006 Feb;111(2):139-49. Epub 2006 Feb 17.

PMID:
16485107
14.

Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease.

Klein WL, Stine WB Jr, Teplow DB.

Neurobiol Aging. 2004 May-Jun;25(5):569-80. Review.

15.

Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.

Tõugu V, Karafin A, Palumaa P.

J Neurochem. 2008 Mar;104(5):1249-59. doi: 10.1111/j.1471-4159.2007.05061.x.

16.

A relationship between Alzheimer's disease and type 2 diabetes mellitus through the measurement of serum amyloid-beta autoantibodies.

Kim I, Lee J, Hong HJ, Jung ES, Ku YH, Jeong IK, Cho YM, So I, Park KS, Mook-Jung I.

J Alzheimers Dis. 2010;19(4):1371-6. doi: 10.3233/JAD-2010-1332.

PMID:
20061608
17.

Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias.

Bibl M, Mollenhauer B, Lewczuk P, Esselmann H, Wolf S, Trenkwalder C, Otto M, Stiens G, Rüther E, Kornhuber J, Wiltfang J.

Mol Psychiatry. 2007 Jul;12(7):671-80. Epub 2007 Mar 6.

PMID:
17339876
18.

Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.

Cerf E, Sarroukh R, Tamamizu-Kato S, Breydo L, Derclaye S, Dufrêne YF, Narayanaswami V, Goormaghtigh E, Ruysschaert JM, Raussens V.

Biochem J. 2009 Jul 15;421(3):415-23. doi: 10.1042/BJ20090379.

PMID:
19435461
19.
20.

Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid.

Schuster D, Rajendran A, Hui SW, Nicotera T, Srikrishnan T, Kruzel ML.

Neuropeptides. 2005 Aug;39(4):419-26.

PMID:
15890402

Supplemental Content

Support Center